SGMT Sagimet Biosciences Inc.
Healthcare · Market cap: not available
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $1.2M | $10.6K |
| 2023-Q4 | $7.9K | $0 |
| 2024-Q1 | $63.8K | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $178.2K |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $771.8K |
| 2025-Q4 | $0 | $289.8K |
| 2026-Q1 | $0 | $105.5K |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $4.5M |
| 2026-Q4 | $0 | $0 |
Bought$1.3M5 buy days
Sold$5.9M18 sell days
Net insider flow-$4.6Mnet selling · 5 years
Latest trade2026-08-14Kemble George
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-08-14 | Sell | Kemble George | Director | 350,987 | $10.23 | $3.6M | 1 |
| 2026-08-11 | Sell | Kemble George | Director | 20,206 | $9.95 | $201.1K | 1 |
| 2026-07-20 | Sell | Happel David | CEO | 64,051 | $7.76 | $497.1K | 1 |
| 2026-07-20 | Sell | Kemble George | Director | 18,844 | $7.46 | $140.5K | 1 |
| 2026-07-20 | Sell | Rozek Elizabeth | Other C-suite | 10,545 | $7.76 | $81.8K | 1 |
| 2026-02-10 | Sell | Happel David | CEO | 12,101 | $5.36 | $64.9K | 1 |
| 2026-02-10 | Sell | Martins Eduardo Bruno | Other C-suite | 3,640 | $5.36 | $19.5K | 1 |
| 2026-02-10 | Sell | Rozek Elizabeth | Other C-suite | 2,622 | $5.36 | $14.1K | 1 |
| 2026-02-10 | Sell | Chauche Thierry | CFO | 1,312 | $5.36 | $7.0K | 1 |
| 2025-11-20 | Sell | Kemble George | Chair | 37,688 | $7.69 | $289.8K | 1 |
| 2025-07-21 | Sell | Happel David | CEO | 65,478 | $9.13 | $597.8K | 1 |
| 2025-07-21 | Sell | Rozek Elizabeth | Other C-suite | 10,780 | $9.13 | $98.4K | 1 |
| 2025-07-21 | Sell | Martins Eduardo Bruno | Other C-suite | 8,277 | $9.13 | $75.6K | 1 |
| 2024-07-23 | Sell | Kemble George | Chair | 23,625 | $3.17 | $74.9K | 1 |
| 2024-07-19 | Sell | Kemble George | Chair | 14,062 | $3.10 | $43.6K | 1 |
| 2024-07-19 | Sell | Rozek Elizabeth | Other C-suite | 10,914 | $3.10 | $33.8K | 1 |
| 2024-07-19 | Sell | Martins Eduardo Bruno | Other C-suite | 8,357 | $3.10 | $25.9K | 1 |
| 2024-03-26 | Buy | Happel David | CEO | 12,100 | $5.27 | $63.8K | 1 |
| 2023-12-07 | Buy | Happel David | CEO | 1,600 | $4.10 | $6.6K | 1 |
| 2023-11-16 | Buy | Happel David | CEO | 590 | $2.35 | $1.4K | 1 |
| 2023-07-18 | Buy | SEIDENBERG BETH C | Director | 46,875 | $16.00 | $750.0K | 1 |
| 2023-07-18 | Buy | KERINS PATRICK J | 10% owner | 30,000 | $16.00 | $480.0K | 1 |
| 2023-07-18 | Sell | KERINS PATRICK J | 10% owner | 662 | $16.00 | $10.6K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Kemble George | Director | $0 | $4.3M | 2026-08-14 |
| Happel David | CEO | $71.7K | $1.2M | 2026-07-20 |
| SEIDENBERG BETH C | Director | $750.0K | $0 | 2023-07-18 |
| KERINS PATRICK J | 10% owner | $480.0K | $10.6K | 2023-07-18 |
| Rozek Elizabeth | Other C-suite | $0 | $228.1K | 2026-07-20 |
| Martins Eduardo Bruno | Other C-suite | $0 | $121.0K | 2026-02-10 |
| Chauche Thierry | CFO | $0 | $7.0K | 2026-02-10 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.